PharmoRx Therapeutics
Robert "Bob" Kessler is a co-founder PharmoRx Therapeutics. Together with David Bear, he patented the invention to develop novel uses of established dopamine-active agents in neuropsychiatry. Bob is a neuroradiologist with over 30 years of experience in both PET and MRI imaging, both at a clinical and research level. He holds patents both in development of dopamine D2 receptor ligands and in development of MRI pulse sequences.
This person is not in any offices
PharmoRx Therapeutics
PharmoRx Therapeutics' mission is to create therapies for treating dopamine-related central nervous system diseases.